Shoreline Biosciences

0 followers


Shoreline's proprietary cell therapy technology platform is based on deep expertise in iPSC differentiation methods and genetic programming of the IL-15/CISH pathway for enhanced metabolic fitness and persistence of the engineered NK Cells to improve anti-cancer activity.

Employees

11-50

Links

Org chart

Kleanthis G. Xanthopoulos

Collapse
Robert Hollingsworth
Chief Scientific Officer
Scott Forrest
Chief Business Officer
Mauro P. Avanzi
Chief Medical Officer
Steven Neben
VP, Alliance & Project Management
Krishna Patel
HR Manager

Board & advisors

Dan S. Kaufman
Co-Founder, Chair of SAB
Steven Holtzman
Co-Founder & Board Member
Marios Fotiadis
Board Member
Scott Antonia
Advisory Board Member
Silke Paust
Advisory Board Member
Judith Shizuru
Advisory Board Member
Travis S. Young
Advisory Board Member
Frank Yu
Director